Back to Man Group plc Man Group plc

PTGXPTGX

Showing 5 of 10 quarters

Position history for Man Group plcMan Group plc's holdings in PROTAGONIST THERAPEUTICS INC

No. Man Group exited its PTGX (Protagonist Therapeutics) position in Q3 2025. Its Q2 2025 13F listed 34,013 shares worth $1.9M. Man Group first reported PTGX in Q2 2022 and held it in 8 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$2.5M

Total Shares Change

-55,831

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$66.43
0
2025-Q2
Decreased
34,013
-73.5%
$1.9M0.0%$55.27
0
2025-Q1
Decreased
128,606
-18.6%
$6.2M0.0%$48.36
0
2024-Q4
Increased
157,963
+182.9%
$6.1M0.0%$38.60
44
2024-Q3
Increased
55,831
+629.3%
$2.5M0.0%$45.00
42

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used